Urology · Woodbridge, VA
NPI
1811168966
Since 2008
Specialty
Urology
Code 208800000X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
2296 Opitz Blvd, Suite 350
Woodbridge, VA, 22191
Phone (703) 680-2111
Groups this clinician bills Medicare through
Medicare paid, 2024
$581K
18,652 services
Medicare patients, 2024
1,512
Average age 76
Drug cost, 2024
$503K
3,487 prescriptions
Company payments, 2025
$704
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alok S Desai was code J0585 (injection, onabotulinumtoxina, 1 unit), 1,800 times for 15 patients. In total Alok S Desai billed 18,652 services in 120 codes, and Medicare paid $581K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-10-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 1,800 | 15 | $4.79 | $8,614 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,173 | 811 | $12.36 | $15K |
| 99214 Office E&M - Established | Office | 1,100 | 772 | $95.60 | $105K |
| 81002 Clinical Chemistry | Office | 607 | 483 | $3.37 | $2,043 |
| 99213 Office E&M - Established | Office | 601 | 525 | $67.70 | $41K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 505 | 91 | $53.96 | $27K |
| 51798 Ultrasound - Nonspecific | Office | 325 | 267 | $8.86 | $2,878 |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 312 | 23 | $34.39 | $11K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 252 | 39 | $51.62 | $13K |
| 99459 Office/Outpatient Services | Office | 224 | 208 | $16.76 | $3,754 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 215 | 63 | $41.59 | $8,942 |
| 99204 Office E&M - New | Office | 198 | 198 | $119.50 | $24K |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 120 | 23 | $34.39 | $4,127 |
| 52000 Cystourethroscopy | Office | 100 | 94 | $189.38 | $19K |
| 99212 Office E&M - Established | Office | 97 | 89 | $39.90 | $3,870 |
By year: 2022 $478K for 16,330 services; 2023 $475K for 17,791 services; 2024 $581K for 18,652 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 607 | 483 | $3.37 | $2,043 |
| 87798 Infectious Agent Detection by DNA/RNA | 312 | 23 | $34.39 | $11K |
| 87481 Infectious Agent Detection by DNA/RNA | 120 | 23 | $34.39 | $4,127 |
| 87801 Infectious Agent Detection by DNA/RNA | 72 | 23 | $68.80 | $4,953 |
| 87641 Infectious Agent Detection by DNA/RNA | 37 | 35 | $34.39 | $1,272 |
| 87640 Infectious Agent Detection by DNA/RNA | 37 | 35 | $34.39 | $1,272 |
| 87651 Infectious Agent Detection by DNA/RNA | 24 | 23 | $34.39 | $825 |
| 87653 Infectious Agent Detection by DNA/RNA | 24 | 23 | $34.39 | $825 |
| 87500 Infectious Agent Detection by DNA/RNA | 24 | 23 | $34.39 | $825 |
Medicare prescription drug claims, 2024
In 2024, the drug Alok S Desai prescribed most often to Medicare patients was Trospium Chloride, with 578 prescriptions and refills. In total Alok S Desai wrote 3,487 Medicare prescriptions that cost $503K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trospium Chloride Generic | 578 | 1,135 | 258 | $44K |
| Solifenacin Succinate Generic | 555 | 1,189 | 226 | $36K |
| Methenamine Hippurate Generic | 415 | 924 | 152 | $40K |
| Estradiol Generic | 372 | 642 | 213 | $26K |
| Myrbetriq Mirabegron | 260 | 434 | 89 | $191K |
| Tamsulosin Hcl Generic | 249 | 593 | 102 | $3,125 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 109 | 141 | 67 | $2,504 |
| Gemtesa Vibegron | 84 | 152 | 34 | $70K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 77 | 77 | 67 | $254 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 66 | 170 | 36 | $1,271 |
| Cefuroxime Cefuroxime Axetil | 66 | 66 | 59 | $879 |
| Fluconazole Generic | 46 | 46 | 36 | $188 |
| Clobetasol Propionate Generic | 44 | 54 | 17 | $1,380 |
| Desmopressin Acetate Generic | 39 | 65 | 19 | $1,531 |
| Cephalexin Generic | 37 | 41 | 29 | $334 |
Brand drugs: - claims; generic drugs: 3,052 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alok S Desai $704 ($704 in general payments such as food, travel and fees) from 7 companies. The largest payer was Calyxo, Inc. with $319.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.